A citation-based method for searching scientific literature

Steven E Artandi, Scott Alson, Maja K Tietze, Norman E Sharpless, Siqin Ye, Roger A Greenberg, Diego H Castrillon, James W Horner, Sarah R Weiler, Ruben D Carrasco, Ronald A DePinho. Proc Natl Acad Sci U S A 2002
Times Cited: 229



J W Shay, S Bacchetti. Eur J Cancer 1997
Times Cited: 2127




List of shared articles



Times cited

Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways.
Somayyeh Ghareghomi, Shahin Ahmadian, Nosratollah Zarghami, Houman Kahroba. Biochimie 2021
6

Non-canonical Roles of Telomerase: Unraveling the Imbroglio.
Evelyne Ségal-Bendirdjian, Vincent Geli. Front Cell Dev Biol 2019
23

Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Rong Bu, Abdul K Siraj, Sasidharan Padmaja Divya, Yan Kong, Sandeep Kumar Parvathareddy, Maha Al-Rasheed, Khadija A S Al-Obaisi, Ingrid G Victoria, Saif S Al-Sobhi, Mohammed Al-Dawish,[...]. Int J Cancer 2018
31

Involvement of telomerase activity inhibition and telomere dysfunction in silver nanoparticles anticancer effects.
Biao Chen, Yajun Zhang, Yaning Yang, Shaopeng Chen, An Xu, Lijun Wu, Shengmin Xu. Nanomedicine (Lond) 2018
2

Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.
Weibo Yu, Xiaotian Qin, Yusheng Jin, Yawei Li, Chintda Santiskulvong, Victor Vu, Gang Zeng, Zuofeng Zhang, Michelle Chow, Jianyu Rao. Oncotarget 2017
9

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
36

Current Insights to Regulation and Role of Telomerase in Human Diseases.
Mert Burak Ozturk, Yinghui Li, Vinay Tergaonkar. Antioxidants (Basel) 2017
34

Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Karima Ait-Aissa, Johnathan D Ebben, Andrew O Kadlec, Andreas M Beyer. Pharmacol Res 2016
22

Telomeres in aging and disease: lessons from zebrafish.
Madalena C Carneiro, Inês Pimenta de Castro, Miguel Godinho Ferreira. Dis Model Mech 2016
50

Repression of hTERT transcription by the introduction of chromosome 3 into human oral squamous cell carcinoma.
Sachiyo Nishio, Takahito Ohira, Naohiro Sunamura, Mitsuo Oshimura, Kazuo Ryoke, Hiroyuki Kugoh. Biochem Biophys Res Commun 2015
3

Telomerase modulation in therapeutic approach.
Aleksandra Romaniuk, Przemyslaw Kopczynski, Krzysztof Ksiazek, Blazej Rubis. Curr Pharm Des 2014
7

The role of telomere biology in cancer.
Lifeng Xu, Shang Li, Bradley A Stohr. Annu Rev Pathol 2013
94

Sowing the seeds of cancer: telomeres and age-associated tumorigenesis.
Branca Pereira, Miguel G Ferreira. Curr Opin Oncol 2013
15

Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.
Hae-Yun Jung, Xin Wang, Sohee Jun, Jae-Il Park. J Biol Chem 2013
41

Telomerase at the intersection of cancer and aging.
Bruno Bernardes de Jesus, Maria A Blasco. Trends Genet 2013
110

Telomerase: central regulator of all of the hallmarks of cancer.
Kee Chung Low, Vinay Tergaonkar. Trends Biochem Sci 2013
158

Telomere biology: cancer firewall or aging clock?
J J Mitteldorf. Biochemistry (Mosc) 2013
11

InTERTesting association between telomerase, mTOR and phytochemicals.
Tabetha Sundin, Patricia Hentosh. Expert Rev Mol Med 2012
25


Regulation of senescence in cancer and aging.
Yahui Kong, Hang Cui, Charusheila Ramkumar, Hong Zhang. J Aging Res 2011
39

A Cajal body-independent pathway for telomerase trafficking in mice.
Rebecca L Tomlinson, Jian Li, Bradley R Culp, Rebecca M Terns, Michael P Terns. Exp Cell Res 2010
22